To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Immunohistochemical valid… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomasn

Journal article
Authors Hanna Engqvist
Toshima Z Parris
Anikó Kovács
Szilard Nemes
Elisabeth Werner Rönnerman
Shahin De Lara
Jana Biermann
Karin Sundfeldt
Per Karlsson
Khalil Helou
Published in BMC Cancer
Volume 19
Issue 1
ISSN 1471-2407
Publication year 2019
Published at Institute of Clinical Sciences, Department of Oncology
Sahlgrenska Cancer Center
Institute of Clinical Sciences, Department of Obstetrics and Gynecology
Institute of Clinical Sciences, Department of Orthopaedics
Language en
Links dx.doi.org/10.1186/s12885-019-6084-...
Keywords Ovarian cancer, Prognostic biomarker, Immunohistochemistry, Mucinous, ovarian cancer, Clear-cell ovarian cancer, protein-coupled receptors, drug discovery, cancer, expression, collagen, survival, abundance, targets, ca125, model, Oncology
Subject categories Cancer and Oncology

Abstract

Background: Ovarian cancer is the main cause of gynecological cancer-associated death. However, 5- Methods: Here, we evaluated the prognostic role of 29 genes for early-stage (I and II) ovarian Results: We provide evidence of aberrant protein expression patterns for Collagen type III alpha 1 Conclusions: The novel biomarkers identified here may improve prognostication at the time of

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?